Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
NCT06483659Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin in postoperative pain (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Post-operative pain. Started Jun 2025; status: recruiting.
02
Drugs
oxytocin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06483659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06483659.